Search - tctmd.com

Displaying 701 - 720 of 788

Sort: Relevancy | Date

News Daily News

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

February 07, 2012

News Daily News

New Revascularization Appropriateness Criteria Feature PCI Upgrades

January 31, 2012

Presentation TCT 2012

The Association of Pre-infarction Angina, Pre-procedural Thrombolysis in Myocardial Infarction Flow and Collateral Flow with Myocardial Salvage in Patients with ST-Segment...

Presenter: Jacob T. L?nborg, Niels Vejlstrup, Henning Kelb?k, Hans E. B?tker, Won Y. Kim, Lene Holmvang, Erik J?rgensen, Steffen Helqvist, Peter Clemmensen, Kari Saunamaki, Leif Thuesen, Lars R. Krusell, Thomas Engstr?m

January 03, 2012

Presentation TCT 2012

Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina

Presenter: Hiromasa Otake, Junya Shite, Toshiro Shinke, Ken-ichi Hirata

January 03, 2012

Presentation TCT 2012

Can Metabolic Syndrome Predict the Vulnerable Plaque in Patients with Stable Angina Pectoris?: Virtual Histology-Intravascular Ultrasound Analysis

Presenter: Min Goo Lee, Keun-Ho Park, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Myung Ho Jeong

January 03, 2012

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Daily News

Surgical Backup for PCI Makes No Difference in Rates of Death, CABG

L.A. McKeown

December 12, 2011

News Daily News

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

Leah Lawrence

December 08, 2011

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

November 10, 2011

News Industry News

Gilead Sciences, CRF commence Ranolazine trial to treat MACE

November 09, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

Advertisement

Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011

New Revascularization Appropriateness Criteria Feature PCI Upgrades

The Association of Pre-infarction Angina, Pre-procedural Thrombolysis in Myocardial Infarction Flow and Collateral Flow with Myocardial Salvage in Patients with ST-Segment...

Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina

Can Metabolic Syndrome Predict the Vulnerable Plaque in Patients with Stable Angina Pectoris?: Virtual Histology-Intravascular Ultrasound Analysis

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

Surgical Backup for PCI Makes No Difference in Rates of Death, CABG

LIPSIA: No Rush for Treatment of High-Risk NSTEMI Patients

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

Gilead Sciences, CRF commence Ranolazine trial to treat MACE

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

OrbusNeich’s Genous Stent Demonstrates Most Rapid Coronary Vessel Healing Compared to Bare Metal and Drug Eluting Stents at 14 Days Post-Implantation

Ongoing Trials Explore Potential Benefits of Transradial PCI

Low Event Rates with EES Sustained at 2 Years

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content